Exposure to SARS-CoV-2 does not guarantee infection. Even in the closest possible quarters, such as sharing a home with someone actively sick, a substantial fraction of people walk away without ever testing positive. A meta-analysis of household transmission studies estimated that only about one in six susceptible contacts actually caught the virus from an infected housemate, and even a deliberate human challenge trial, where researchers dripped live virus directly into volunteers’ noses, failed to infect nearly half of them. The reasons span genetics, prior immunity, dose of exposure, age, and the state of your immune system at the moment the virus arrives.
What Household Studies Tell Us
Households are the tightest transmission setting most people encounter. You share air, surfaces, and bathrooms with an infected person for days. Yet the secondary attack rate in households has consistently landed well below 100%. A large systematic review and meta-analysis published in JAMA Network Open found the overall household secondary attack rate to be about 17%, meaning roughly five out of six household contacts did not become infected.1JAMA Network Open. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis A similar study from Wuhan estimated a rate of about 16%.2The Lancet Infectious Diseases. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study
Those averages hide enormous variation, though. The JAMA meta-analysis found that spouses of infected people had a secondary attack rate close to 38%, while other family contacts were closer to 18%. Adults were more likely to catch it than children. And smaller households were riskier: contacts in one-person households had an attack rate over 40%, while those sharing a house with three or more people had roughly 23%.1JAMA Network Open. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis One U.S. study found a much higher household attack rate of 60%, but that study focused on densely populated housing and likely captured a setting with more sustained, close-range exposure.3PubMed Central. High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color The takeaway is that even under prolonged, intimate exposure, infection is far from inevitable.
The Human Challenge Trial
The clearest evidence that exposure does not equal infection comes from an unusual experiment. In 2022, researchers in the UK deliberately inoculated 36 young, healthy, unvaccinated volunteers by placing a measured dose of SARS-CoV-2 into their nostrils. About 53% developed confirmed infection. The other 47% inhaled the same virus but never showed sustained viral replication on repeated PCR tests.4Nature Medicine. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults That is a controlled, standardized dose of virus delivered directly to the site of infection, in people with no prior immunity. Nearly half of them still didn’t get sick. Something biological was stopping the virus from gaining a foothold.
Follow-up single-cell genomic work on those challenge participants revealed that resistance was not simply a matter of the virus failing to land in the right place. Among those who stayed uninfected, researchers could detect brief, abortive infections: the virus entered some cells, triggered a rapid immune reaction, and was cleared before it could spread. The response involved fast activation and expansion of specific T cell populations in the nose and blood.4Nature Medicine. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Abortive Infections and the T Cells That Stop Them
One of the more surprising discoveries of the pandemic was that some people appeared to fight off SARS-CoV-2 so quickly that they never produced detectable antibodies. These so-called “abortive infections” were identified among healthcare workers in London who were heavily exposed during the first wave yet remained both PCR-negative and seronegative. Despite appearing untouched, their blood told a different story: T cells specific to the virus’s internal replication machinery expanded in the weeks after exposure, proving that the immune system had encountered the virus and dealt with it.5Nature. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
These T cells were not random. They targeted the virus’s replication-transcription complex, the internal engine that copies the viral genome. People who had higher levels of these T cells before exposure were more likely to clear the virus before it could establish a real infection. The phenomenon is not unique to SARS-CoV-2; similar patterns of abortive infection have been documented with HIV, hepatitis B, and hepatitis C, suggesting a broader principle of T cell-mediated sterilizing defense.6PubMed Central. Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
Cross-Reactive Immunity from Common Colds
Where did those protective T cells come from if the people had never had COVID? The leading explanation is prior infection with ordinary human coronaviruses, the ones that circulate every winter and cause common colds. Four seasonal coronaviruses are widespread in humans, and researchers demonstrated that memory T cells generated against these viruses can cross-react with SARS-CoV-2, recognizing shared structural features.7PubMed Central. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans These cross-reactive cells could mount a faster defense upon encountering the new virus.
A study of confirmed COVID-19 contacts found that people who stayed PCR-negative despite exposure had higher levels of cross-reactive memory T cells than those who became infected. The protective T cells targeted the nucleocapsid protein and other non-spike parts of the virus, regions that are more conserved between coronaviruses.8Nature Communications. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts Theoretical modeling has proposed several pathways by which these cells could help: speeding up antibody production, directly killing infected cells in the airways, or reducing viral load enough that a full-blown infection never takes hold.9Nature Reviews Immunology. Cross-reactive memory T cells and herd immunity to SARS-CoV-2
The Front Line in Your Nose
Much of the battle between SARS-CoV-2 and your body happens before the virus ever reaches the lungs. The mucosal immune system lining the nose and throat is the first barrier, and it can determine whether an exposure becomes an infection. IgA antibodies secreted onto mucosal surfaces can neutralize virus right at the point of entry, and local immune cells can launch a rapid inflammatory response that walls off the infection. Reviews of mucosal immunity in COVID-19 have emphasized that this local response is likely key to understanding why so many infections stay asymptomatic or never take hold at all.10PubMed Central. Mucosal immunity in COVID-19: a comprehensive review
Natural killer cells, part of the innate immune system, also play a role in early viral control. These cells can destroy virus-infected cells without needing to have seen the virus before, offering a fast, nonspecific line of defense. Evidence indicates that people who mount a strong natural killer cell response tend to have better clinical outcomes.11PubMed Central. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Your Genes Help Determine the Outcome
Genetics influence susceptibility on several fronts. The most studied genetic link involves human leukocyte antigen (HLA) genes, which control how the immune system presents viral fragments to T cells. A study of over a thousand people found that carriers of HLA-B*15:01 were roughly 2.4 times more likely to remain completely asymptomatic after infection compared to people without that allele. Individuals carrying two copies were more than eight times as likely to stay symptom-free.12Nature. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection Different HLA alleles have also been linked to varying susceptibility to testing positive in the first place, though these associations differ across ethnic groups.13Genes & Immunity. Association between HLA genetics and SARS-CoV-2 infection in a large real-world cohort
The virus enters human cells by latching onto a protein called ACE2 on the cell surface. Naturally occurring genetic variants of ACE2 can change how tightly the virus binds. Some variants increase binding affinity, potentially raising susceptibility, while others reduce it. Researchers identified one variant, D355N, that restricts the interaction between ACE2 and the spike protein enough to limit infection in lab experiments and animal models.14PubMed Central. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection Other studies have cataloged more than a dozen ACE2 variants predicted to be protective and several predicted to increase susceptibility, and biochemical testing has confirmed altered binding for a handful of them.15Communications Biology. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
Blood type adds a small additional wrinkle. A large Canadian study found that people with type O blood had about a 12% lower relative risk of testing positive for SARS-CoV-2 compared to non-O types, and a similar reduction in risk of severe illness or death.16PubMed Central. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness A meta-analysis confirmed the trend, estimating the odds of infection for type O were about 19% lower than for other blood types.17PubMed Central. ABO blood group and COVID-19: an updated systematic literature review and meta-analysis The effect is modest, not the kind of thing that will reliably keep you safe on its own, but it adds to the pile of biological variation that separates those who get infected from those who don’t.
Why Children Handle It Differently
One of the most consistent patterns of the pandemic has been that children, especially young children, are less likely to become seriously ill and may be less susceptible to infection in the first place. A review of the proposed mechanisms concluded that the strongest explanation is a faster and more potent innate immune response in children’s nasal passages, which rapidly controls the virus before it can spread deeper into the body.18PubMed Central. Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection Researchers initially hypothesized that children might express less ACE2 in their airways, giving the virus fewer doors to enter, but detailed studies comparing children and adults found no meaningful difference in ACE2 or related entry-factor expression.19Nature Biotechnology. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children The advantage appears to be immunological, not architectural. Children’s upper airways are primed with a higher baseline level of antiviral gene activity, essentially on alert before any virus shows up.
How Much Virus You Inhale Matters
Not all exposures are equal. A brief encounter with someone mildly infectious outdoors is a different proposition from sitting in a poorly ventilated room with a person shedding high levels of virus. The infectious dose of SARS-CoV-2, the amount of virus needed to establish an infection, has been estimated from superspreader event modeling at roughly a few hundred to a few thousand viral particles.20PLOS ONE. Finding the infectious dose for COVID-19 by applying an airborne-transmission model to superspreader events Whether you reach that threshold depends on ventilation, proximity, duration of contact, and how much virus the infected person is producing.
Animal studies of coronaviruses have consistently shown that higher doses at exposure lead to higher viral loads and more severe disease, while lower doses are more likely to result in mild or no infection.21Epidemiology & Infection. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses The meta-analysis data align with this: the JAMA review found that when the index case was asymptomatic (and presumably shedding less virus), the household secondary attack rate dropped to under 1%, compared to 18% for symptomatic index cases.1JAMA Network Open. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis Dose is probably one of the biggest reasons people escape infection after a fleeting exposure.
Ventilation and Environmental Conditions
The physical environment shapes how much virus reaches your airways. Ventilation rate is consistently the most powerful modifiable factor. Modeling work has shown that increasing air exchange from a low baseline to about six air changes per hour can reduce SARS-CoV-2 infection risk by roughly 75 to 78%.22Scientific Reports. Modeling the impact of indoor relative humidity on the infection risk of five respiratory airborne viruses That dwarfs the effect of humidity, which for SARS-CoV-2 turns out to be ambiguous. Lab studies have produced conflicting results on whether higher humidity helps or hurts the virus’s survival.23PLOS ONE. The impact of heating, ventilation and air conditioning (HVAC) design features on the transmission of viruses, including the 2019 novel coronavirus (COVID-19): A systematic review of humidity Fresh air reliably helps; fiddling with your humidifier is less clear-cut.
Vaccination and the Antibody Threshold
Vaccination does not make you completely impervious to infection, but it shifts the odds. A prospective study of vaccinated household contacts in Israel found that people with higher baseline antibody levels at the time of exposure were less likely to become infected and, if they did, had milder disease. Each tenfold increase in IgG antibody concentration cut the odds of infection by more than half.24The Lancet Infectious Diseases. Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study The relationship was dose-dependent: the more antibody on board, the better the protection. This helps explain why protection against infection wanes as antibodies decline over months, even while protection against severe disease, which relies more on memory T and B cells, persists longer.
The Variant Factor
Not all versions of the virus are equally easy to dodge. The Omicron variant, which became dominant in late 2021, was substantially more transmissible within households than Delta, both among unvaccinated people and among those who had received two or three vaccine doses.25Nature Communications. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants Omicron’s advantage came partly from genuine increases in transmissibility and partly from its ability to evade existing immunity, whether from vaccination or prior infection. South African data showed clear population-level evidence of immune escape by Omicron, something that had not been seen with Beta or Delta.26PubMed Central. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa The practical consequence: your chances of avoiding infection after a given exposure depend partly on which lineage is circulating and how well your existing immune memory matches it.
Sleep, Stress, and Susceptibility
The state of your body at the moment of exposure matters in ways that go beyond genetics and antibodies. Mouse studies have shown that even a single bout of sleep deprivation dramatically alters gene expression in the lungs, suppressing immune and circadian-regulated genes while upregulating host factors that the virus exploits for entry and replication.27iScience. Acute sleep deprivation alters the lung transcriptional landscape and “primes” the tissue for viral infection This is consistent with a long line of research on other respiratory viruses showing that sleep-deprived people are more likely to catch colds. The biology points in the same direction for SARS-CoV-2: being run-down at the time of exposure probably shifts the odds against you, even if the effect is hard to quantify precisely in humans.
Nasal Vaccines and Blocking Infection at the Source
Current COVID-19 vaccines, delivered by injection into muscle, are good at preventing severe disease but less effective at stopping the virus from entering and replicating in the nose. That is because injected vaccines primarily generate immune responses in the blood and lymph nodes rather than at the mucosal surfaces where the virus first lands. Intranasal vaccines aim to close that gap by generating immunity directly in the airways. In hamster studies, an intranasal vaccine combining spike and nucleocapsid proteins eliminated viral replication in both the lungs and the nasal passages and prevented transmission to unvaccinated cage-mates.28Nature Communications. Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters Separately, a nasal subunit vaccine showed it could elicit both mucosal and systemic neutralizing antibodies in mice, with cross-protection against multiple variants.29PubMed Central. Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants These are still in development for humans, but the principle is straightforward: if you want to prevent infection rather than just prevent hospitalization, the immune response needs to be waiting where the virus arrives.
What Bats Can Teach Us About Coexisting with Coronaviruses
Bats carry an extraordinary diversity of coronaviruses, often without getting sick. Research into how they manage this has revealed that bats have evolved dampened inflammatory responses. A key sensor of cellular stress and viral invasion, which in humans drives fever and tissue damage, is dialed down at both the genetic and protein level in bats. Reducing this inflammatory reaction does not seem to help bats eliminate viruses faster; instead, it lets them tolerate viral replication without the destructive immune overreaction that causes disease in humans.30Nature. Lessons from the host defences of bats, a unique viral reservoir Understanding this tolerance strategy has informed thinking about why some people, particularly those whose immune systems mount a quick but measured response, handle SARS-CoV-2 exposure without illness while others, whose immune systems overreact, develop severe disease. The lesson from bats is not that we should suppress our immune systems but that the quality of the early response matters as much as its strength.